Lv5
1320 积分 2024-07-23 加入
Characterization of anti-CD3 antibodies in clinically available bispecific T cell engagers
7天前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
19天前
已完结
Progress in the development of cytokine armoured CAR T cells
1个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
2个月前
已完结
The dawn of in vivo immune cell engineering in oncology
2个月前
已完结
An IL-12 renaissance: Engineering tumor-restricted IL-12 to improve solid tumor T cell therapies
3个月前
已完结
Disruption of oncogenic liver-intestine cadherin (CDH17) drives apoptotic pancreatic cancer death
3个月前
已完结
Eleven clinical trials that will shape medicine in 2026
3个月前
已完结
Co-expression of IL-12 receptors along with CXCR3 and CD25 on activated peripheral blood T lymphocytes
3个月前
已完结
Detection of cadherin-17 in human colon cancer LIM1215 cell secretome and tumour xenograft-derived interstitial fluid and plasma
3个月前
已完结
皖公网安备34019202002308
